Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06168994
PHASE4

Role of Eplerenone in Reducing Recurrence of Atrial Fibrillation in Patient With Structural Heart Disease

Sponsor: Assiut University

View on ClinicalTrials.gov

Summary

The aim of this study is to study synergistic effect of eplerenone as Selective aldosterone receptor antagonist with amiodarone compared with amiodarone only in reducing recurrence of atrial fibrillation in patient with structural heart disease

Key Details

Gender

All

Age Range

Any - Any

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2024-02-01

Completion Date

2027-05-20

Last Updated

2023-12-13

Healthy Volunteers

No

Interventions

DRUG

Eplerenone

Amiodarone vs eplerenone in AF